Pharmaceutical / Drug Definition :
Interferes with bacterial cell-wall synthesis and division by binding to cell wall, causing cell to die. Active against gram-negative and gram-positive bacteria, with expanded activity against gram-negative bacteria. Exhibits minimal immunosuppressant activity.
In the United States, Cefpodoxime Proxetil is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Cefpodoxime Proxetil.
FDA Label Requirements and Exceptions
FDA Import Information
Cefpodoxime Proxetil (Cefpodoxime Proxetil Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Cefpodoxime Proxetil (Cefpodoxime Proxetil Suppliers)
- Processors Cefpodoxime Proxetil
- Repackers Cefpodoxime Proxetil
- Relabelers Cefpodoxime Proxetil
- Exporters Cefpodoxime Proxetil
- Importers Cefpodoxime Proxetil
For more information about Cefpodoxime Proxetil, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.